ID: ALA2235242

Max Phase: Preclinical

Molecular Formula: C19H18O6

Molecular Weight: 342.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1c(OC(C)C)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12

Standard InChI:  InChI=1S/C19H18O6/c1-10(2)24-16-9-14(22)17-13(21)8-15(25-19(17)18(16)23-3)11-4-6-12(20)7-5-11/h4-10,20,22H,1-3H3

Standard InChI Key:  OBNGERGWZDHLKG-UHFFFAOYSA-N

Associated Targets(non-human)

Avian myoblastosis virus polyprotein II 68 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 342.35Molecular Weight (Monoisotopic): 342.1103AlogP: 3.67#Rotatable Bonds: 4
Polar Surface Area: 89.13Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.82CX Basic pKa: CX LogP: 3.47CX LogD: 3.32
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.75Np Likeness Score: 1.08

References

1. Phosrithong N, Samee W, Ungwitayatorn J.  (2012)  3D-QSAR studies of natural flavonoid compounds as reverse transcriptase inhibitors,  21  (5): [10.1007/s00044-011-9570-z]

Source